Carle Cancer Center Community Clinical Oncology Program

描述(由申请人提供)：为了响应RFA-CA-12-007，美国国家癌症研究所社区临床肿瘤学计划(CCOP)，位于伊利诺伊州厄巴纳的Carle癌症中心正在申请继续作为伊利诺伊州中东部CCOP的资助。Carle癌症中心CCOP由一个主要基地和两个组成部分组成，自1983年CCOP成立以来一直得到资助。Carle现在是一家综合性医疗组织，将一个以研究为导向的医疗服务网络整合在一起。这个网络的核心是Carle Foundation医院、Carle医生集团和健康联盟医疗计划。CARLE CCOP拥有一家拥有325张床位的一级创伤医院，300多名医生团队，以及一款自有的医疗保险产品，拥有推进其研究使命所需的资源。伊利诺伊州奥罗拉的Rush-Copley医疗中心和印第安纳州密歇根市的Franciscan St.Anthony Health作为组成机构加入了Carle CCOP。总体而言，集水区有400多万人，其中130万是少数民族。CCOP的主要研究基地位于伊利诺伊州的厄巴纳，所有注册、随机化、质量保证和数据管理都在这里进行。CCOP的主要研究基地隶属于联盟。此外，Carle癌症中心CCOP是东部合作肿瘤学小组(ECOG)、国家外科辅助乳肠计划(NSABP)、放射治疗肿瘤学小组(RTOG)、妇科肿瘤小组(GOG)和癌症试验支持单位(CTSU)的长期成员。此外，今年春天，卡尔癌症中心CCOP加入了阳光海岸CCOP研究基地。Carle CCOP最近经历了一倍的应计比率，并充分预计在未来五年内468名治疗对象和703名癌症控制对象的应计比率。CCOP拥有一支由12名调查人员、50多名工作人员组成的敬业研究团队，以及互动的行政支持，为成功做好了准备。基于以研究为导向的文化、经验丰富和敬业的调查人员以及无可挑剔的监管标准，Carle CCOP定位于为其服务的社区提供最高水平的护理。

DESCRIPTION (provided by applicant): In response to RFA-CA-12-007, Community Clinical Oncology Program (CCOP), National Cancer Institute, the Carle Cancer Center located in Urbana, Illinois is applying for continued funding as an East Central Illinois CCOP. The Carle Cancer Center CCOP, consisting of a main base and two components, has been continually funded since the inception of the CCOP in 1983. Carle, now an integrated healthcare organization, brings together a research-driven network of healthcare services. At the core of this network reside the Carle Foundation Hospital, Carle Physician Group and Health Alliance Medical Plans. With a 325-bed Level I trauma hospital, over 300 physician group, and a self-owned health insurance product, the Carle CCOP possesses the resources necessary to further its research mission. Joining the Carle CCOP as component institutions are Rush-Copley Medical Center in Aurora, Illinois and Franciscan St. Anthony Health in Michigan City, Indiana. Altogether, the catchment area consists of over 4 million people of which 1.3 million are minorities. The CCOP's primary research base is located in Urbana, Illinois where all registration, randomization, quality assurance, and data management are conducted. The CCOP's primary research base affiliation is with Alliance. Additionally, the Carle Cancer Center CCOP is long-standing members of the Eastern Cooperative Oncology Group (ECOG), the National Surgical Adjuvant Breast and Bowel Project (NSABP), the Radiation Therapy Oncology Group (RTOG), the Gynecological Oncology Group (GOG), and the Cancer Trials Support Unit (CTSU). Additionally, this past spring, the Carle Cancer Center CCOP joined the SunCoast CCOP Research Base. The Carle CCOP has recently experienced a doubling of accrual and fully anticipates accrual rates of 468 treatment subjects and 703 cancer control subjects over the next five years. With a dedicated research team of 12 investigators, over 50 staff members, and interactive administrative support, the CCOP is well-positioned to succeed. Based on a research-driven culture, seasoned and engaged investigators, and impeccable regulatory standards, the Carle CCOP is positioned to provide the highest level of care to the communities it serves.